COMMUNIQUÉS West-GlobeNewswire

Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation
15/10/2025
Nasdaq Hearing Cancellation and Continued Listing FOSTER CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a California based late-stage clinical [...]
Vara obtient le marquage CE en tant que seule IA autorisée pour une deuxième lecture indépendante en mammographie et se développe en Europe
15/10/2025
BERLIN, 15 oct. 2025 (GLOBE NEWSWIRE) -- Vara a annoncé aujourd'hui avoir reçu un nouveau certificat CE pour sa nouvelle IA d'imagerie mammaire – la seule sur le marché autorisée à effectuer une deuxième lecture [...]
Tevogen Updates on TVGN 489 Following Growing Long COVID Patient Interest
15/10/2025
Company intends to collaborate with government initiatives, Long COVID patient organizations, and major healthcare providers to expedite development of TVGN 489 In recognition of the high volume of patient inquiries, [...]
PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025
15/10/2025
SAN JOSE, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions [...]
Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to Acquire C2 CryoBalloon Technology
15/10/2025
Asset acquisition would expand Merit’s Endoscopy portfolio with an innovative device to treat patients suffering from Barretts esophagus and other gastrointestinal disorders. Asset acquisition is projected to add [...]
Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025
15/10/2025
SEATTLE, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]
OrthoPediatrics Corp. to Report Third Quarter Financial Results on October 28, 2025
15/10/2025
WARSAW, Ind., Oct. 15, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]
Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $316.2 Million
15/10/2025
WALTHAM, Mass., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose [...]
Eagle Pharmaceuticals Announces Availability of Unaudited Second Quarter 2025 Financial Statements
15/10/2025
WOODCLIFF LAKE, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that the Company’s unaudited financial statements for the three and six [...]
Teladoc Health to Announce Third Quarter 2025 Financial Results
15/10/2025
NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release third quarter 2025 results on Wednesday, October 29, 2025, after the market [...]
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
15/10/2025
FREMONT, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- In a move that strengthens its European operations and enhances service for its customers, spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today [...]
Annovis Announces Closing of $6 Million Registered Direct Offering of Common Stock
15/10/2025
MALVERN, Pa., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases [...]
CORRECTION: Propanc Biopharma Announces Strategic Financing Agreement of up to $100 Million with Hexstone Capital
15/10/2025
Initial Conversion Price of $5.00 Per Share Representing a 280% Premium Over the Company’s Recent Closing Price of $1.78 MELBOURNE, Australia, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. ("Propanc" or the [...]
WeightWatchers for Business Annual Report Shows Breakthrough Weight Loss Results and Health Outcomes
15/10/2025
Members See 46% Improvement in Work-Related Quality of Life and 53% Improvement in Overall Quality of Life WeightWatchers Members Lost 21% of Their Body Weight, Outperforming Results by Other Telehealth Providers NEW [...]
Ketabon Presents New Data Showing Antidepressant Effects of Oral Ketamine (KET01) Are Independent of Dissociation
15/10/2025
Findings Presented at ECNP 2025 in Amsterdam Support the Potential for a Safe At-Home Treatment Option in Treatment-Resistant Depression MUNICH, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Ketabon GmbH (“Ketabon” or “the Company [...]
Eascra Biotech Named to Fast Company’s “Next Big Things in Tech 2025”
15/10/2025
Recognition for groundbreaking work and pioneering space manufacturing BOSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Fast Company has named Eascra Biotech, a nanomedicine startup, to its annual Next Big Things in Tech list [...]
Consortium consisting of Nordic Capital and Permira increases offer price and extends offer period until 5 November 2025 in respect of the takeover offer to the shareholders of Bavarian Nordic
15/10/2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION COPENHAGEN, Denmark, [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 41 - 2025
15/10/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 06 Octobre au 10 Octobre 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 41 - 2025
15/10/2025
Aggregated presentation by day and by market Statement of transactions in own shares from October 06th to October 10th 2025 Name of the issue Identity code of the issuer (Legal Entity Identifier) Day of the transaction [...]

Pages